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Correspondence
Reply
To the Editor—The letter by Sarmati et
al. [1] presents data indicating that they
were unable to find a significant correla-
tion between human herpesvirus
(HHV)–8 seropositivity and a history of
spontaneous abortion in a group of 245
human immunodeficiency virus (HIV)
type 1–seronegative women but that they
did observe a correlation between high
HHV-8 antibody titers (1:1280) and
spontaneous abortion. Although it is pos-
sible that an increased risk of spontaneous
abortion may be associated with active in-
fection with HHV-8, at this point there is
not enough evidence to support such an
association. Given that several human her-
pesviruses are well-known agents of fetal
and/or perinatal infection and that pri-
mary maternal herpesvirus infection prior
to 20 weeks of gestation in some women
has been associated with spontaneous
abortion [2], and given the dearth of in-
formation about the clinical manifesta-
tions of HHV-8 infection, Sarmati et al.
are correct in suggesting that this question
should be investigated further.
However, it is premature to assume on
the basis of the evidence presented by Sar-
mati et al. [1] that an association between
high HHV-8 antibody titers and sponta-
neous abortion exists. There are still a
number of questions that need to be ad-
dressed in relation to spontaneous abor-
tion and maternal HHV-8 infection. In the
study by Sarmati et al., it is not clear
whether the women who had higher an-
tibody titers were undergoing primary in-
fection with HHV-8, as might be suggested
by reactive HHV-8 IgM titers. Were any
of the products of conception necropsied
and examined for possible viral cytopa-
thology? It is also likely that other factors,
such as other opportunistic infections,
may have increased the risk for both spon-
taneous abortion and elevated HHV-8 IgG
titers. Furthermore, no mention of a time
frame between abortion and HHV-8 test-
ing was presented, nor was there any in-
formation on the number of abortions ex-
perienced, only a history of abortion.
Antibody titers likely fluctuate with time,
so it would be difficult to correlate the
HHV-8 antibody titer from a current preg-
nancy with a previous spontaneous abor-
tion event. Nevertheless, Sarmati et al.
have presented an interesting observation
of HHV-8 infection in relation to preg-
nancy in a population of HIV-1–seroneg-
ative women. Further analysis will need to
be performed on a larger population of
HHV-8–seropositive mothers with high
HHV-8 antibody titers (1:1280), to sub-
stantiate the increased risk of spontaneous
abortion among women with high HHV-
8 antibody titers.
We agree with Sarmati et al. [1] that
the role of maternal HHV-8 infection dur-
ing pregnancy and the outcome of in-
fants born to HHV-8–seropositive moth-
ers have not been fully investigated. With
regard to the outcome of infants born to
HHV-8–seropositive women in our study
[3], Sarmati et al. are correct to note that
we did not see a significant difference in
infant mortality between infants born to
HHV-8–seropositive and –seronegative
mothers by 12 months after delivery.
However, we did observe a modest in-
crease in mortality among infants born to
HHV-8–seropositive mothers, compared
with those born to HHV-8–seronegative
mothers (1.8 times more likely), by 36
months after delivery (authors’ unpub-
lished data). The mortality was exacer-
bated in the presence of HIV-1 coinfec-
tion. Our ongoing cohort study of
mother-infant pairs in Zambia focuses
primarily on in utero infection, vertical
transmission of HHV-8, and risk factors
associated with transmission. For this rea-
son, the outcome of previous pregnancies,
with regard to maternal HHV-8 serostatus
or maternal HHV-8 antibody titer, was not
a focus of our study; nevertheless, we did
analyze the number of reported miscar-
riages experienced in prior pregnancies,
using the same population described in
our previous study [3]. SAS software (ver-
sion 8; SAS Institute) was used to generate
odds ratios (ORs) and 95% confidence in-
tervals (CIs), and significance was mea-
sured using the x2 test. A total of 316
mothers who gave birth at the University
Teaching Hospital in Lusaka, Zambia, re-
ported a previous pregnancy; 155 were
HHV-8 seropositive, and 161 were HHV-
8 seronegative, as determined by lytic im-
munofluorescence assay, using BC-3 cells.
Forty (12.7%) of those women report-
ed a miscarriage in a prior pregnancy; of
these, 23 were HHV-8 seropositive, and 17
were HHV-8 seronegative. Similar to what
was reported by Sarmati et al. with regard
to spontaneous abortion, no significant
association was observed between HHV-
8 seropositivity in the mother at delivery
and a history of miscarriage in a prior
pregnancy (OR, 1.48; 95% CI, 0.75–2.88;
). As indicated above, HHV-8 an-Pp .25
tibody titers in the mothers at delivery
were not examined, so any relationship to
miscarriages cannot be assessed at this
time, nor would they be relevant to any
previous spontaneous abortion event.
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